Effect and Safety of Meglumine Iotroxate for Cholangiocystography in Normal Cats

Abstract

The biliary opacification characteristics and toxicity of meglumine iotroxate (Biliscopin) were studied in twenty‐three normal cats. Intravenous administraion of 72 mg/kg of Biliscorpin resulted in opacification of the gallbladder and bile duct 20 minutes after administration. Licking and vomiting appeared in ten of twelve cats immediately after administration. These side‐effects were abolished by administration of an anti‐histaminic agent. Slight elevation in ALT or AST was detected 24 hours after administration of Biliscopin. These findings suggest that Biliscopin can be used safely in the cat.